Govt Job: For IMTech Doctoral Degree in Pharma Job | Salary Rs. 42,000 pm

Established in 1984, the Institute of Microbial Technology (IMTech) is one of the 37 national laboratories, 6 units, and 39 outreach centers of the Council of Scientific and Industrial Research.

Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

In September, 1989, upon completion of the permanent campus, the Institute shifted to occupy an area of about 47 acres, of which the labs covered 22 acres and the residential campus 25 acres.

Post :Senior Project Associate (01 post)

Project titled : “To Study the mechanism of action of spermidine in pathogenesis of Salmonella enterica, shigella flexneri and staphylococcus aureus.”

Project Code : MLP-0042

Essential Qualification :
(i) Master’s Degree in Natural or Agricultural Sciences/ MVSc or bachelor’s degree in Engineering or Technology or Medicine from a recognized University or equivalent; and

(ii) 4 years experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organisations and Scientific activities and services.

OR
Doctoral Degree in Science / Engineering / Technology / Pharma / MD / MS from a recognized University or equivalent

Desirable : The Candidate with an expertise in genetic manipulation, knowledge in animal handling and experience in vivo studies and knowledge in cloning, over-expression and purification of protein is desirable.

Upper Age limit (years) – 40

Monthly Emoluments : Rs.42,000/- + HRA

ROLLING ADVT. NO. 04-02

Related Posts

  • Pharma
  • August 1, 2025
  • 47 views
Trump pressures 17 pharma CEOs to cut US drug prices

WASHINGTON, July 31 (Reuters) – President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash U.S. prescription drug prices to match those paid overseas,…

  • Pharma
  • August 1, 2025
  • 64 views
Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

The headline equity benchmarks ended with significant losses today, as investors turned cautious following the U.S. imposition of steep tariffs on multiple trade partners and the reaffirmation of a 25%…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump pressures 17 pharma CEOs to cut US drug prices

Trump pressures 17 pharma CEOs to cut US drug prices

Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

Karnataka issues order to merge Ayush drug dept with State FDA

Karnataka issues order to merge Ayush drug dept with State FDA

Orchid Pharma buyback rights to novel antibiotic; stock up 5%

Orchid Pharma buyback rights to novel antibiotic; stock up 5%